Commercialization by Array. Subject to the provisions of Section 10.6 below, Array will pay to Oncothyreon a royalty equal to [*]of Net Sales of the Product by Array and its Affiliates in each country of the Territory outside the United States. In any country of the Territory outside the United States and the Major EU Countries, Array shall be entitled to credit [*] of the cost of additional Development performed for such country against the royalty payable to Oncothyreon under this Section 10.3.1 for Net Sales made in such country.
Appears in 1 contract
Sources: Development and Commercialization Agreement (Oncothyreon Inc.)
Commercialization by Array. Subject to the provisions of Section 10.6 below, Array will pay to Oncothyreon a royalty equal to [*]] of Net Sales of the Product by Array and its Affiliates in each country of the Territory outside the United States. In any country of the Territory outside the United States and the Major EU Countries, Array shall be entitled to credit [*] of the cost of additional Development performed for such country against the royalty payable to Oncothyreon under this Section 10.3.1 for Net Sales made in such country.
Appears in 1 contract
Sources: Development and Commercialization Agreement (Array Biopharma Inc)